Final rule · 2025-16629

Advisory Committee; Arthritis Advisory Committee; Termination; Removal From List of Standing Committees

The Food and Drug Administration (FDA or the Agency) is announcing the termination of the Arthritis Advisory Committee (Committee). Due to that termination, this final rule removes the Committee from the Agency's list of standing advisory committees in 21 CFR 14.100.